D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$410M |
| 2 |
Chevron
CVX
|
+$400M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$381M |
| 4 |
Williams Companies
WMB
|
+$300M |
| 5 |
SLB Ltd
SLB
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$358M |
| 3 |
Biogen
BIIB
|
+$306M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$298M |
| 5 |
Bausch Health
BHC
|
+$298M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 11.41% |
| 2 | Technology | 9.4% |
| 3 | Healthcare | 8.95% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
PUT
AB InBev
BUD
$162B
| $1.81M | ﹤0.01% |
15,000
| – | – |
|
2252
NNN REIT
NNN
$9.4B
| $1.81M | ﹤0.01% |
+51,657
| New | +$1.98M |
|
2253
Alaska Air
ALK
$5.47B
| $1.8M | ﹤0.01% |
27,931
-16,368
| -37% | -$1.05M |
|
|
INWK
2254
DELISTED
InnerWorkings, Inc.
INWK
| $1.8M | ﹤0.01% |
269,841
-16,015
| -6% | -$104K |
|
|
CMCSK
2255
CALL
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $1.8M | ﹤0.01% |
30,000
| – | – |
|
|
SMRT
2256
DELISTED
Stein Mart Inc
SMRT
| $1.8M | ﹤0.01% |
171,599
+61,017
| +55% | +$701K |
|
2257
Nelnet
NNI
$4.88B
| $1.79M | ﹤0.01% |
41,321
+4,437
| +12% | +$195K |
|
|
WBMD
2258
CALL
DELISTED
WebMD Health Corp.
WBMD
| $1.77M | ﹤0.01% |
40,000
| – | – |
|
|
SIVB
2259
PUT
DELISTED
SVB Financial Group
SIVB
| $1.77M | ﹤0.01% |
+12,300
| New | +$1.66M |
|
2260
CALL
Lumen
LUMN
$6.22B
| $1.76M | ﹤0.01% |
60,000
| – | – |
|
2261
CALL
CarMax
KMX
$8.22B
| $1.76M | ﹤0.01% |
26,600
| – | – |
|
2262
Costamare
CMRE
$1.85B
| $1.76M | ﹤0.01% |
95,809
+21,082
| +28% | +$409K |
|
2263
PUT
Darling Ingredients
DAR
$9.41B
| $1.76M | ﹤0.01% |
+120,000
| New | +$1.77M |
|
2264
Celldex Therapeutics
CLDX
$2.78B
| $1.76M | ﹤0.01% |
4,646
-2,471
| -35% | -$981K |
|
|
RDUS
2265
DELISTED
Radius Recycling
RDUS
| $1.76M | ﹤0.01% |
100,555
-32,505
| -24% | -$571K |
|
|
DSPG
2266
DELISTED
DSP Group Inc
DSPG
| $1.75M | ﹤0.01% |
169,894
+225
| +0.1% | +$2.55K |
|
|
AXE
2267
PUT
DELISTED
Anixter International Inc
AXE
| $1.75M | ﹤0.01% |
+26,900
| New | +$1.9M |
|
2268
Dr. Reddy's Laboratories
RDY
$9.77B
| $1.75M | ﹤0.01% |
158,305
+8,970
| +6% | +$99K |
|
2269
Acacia Research
ACTG
$455M
| $1.74M | ﹤0.01% |
198,848
+109,021
| +121% | +$1.12M |
|
2270
Omnicell
OMCL
$1.94B
| $1.74M | ﹤0.01% |
46,254
+25,821
| +126% | +$942K |
|
|
CSOD
2271
PUT
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $1.74M | ﹤0.01% |
+50,000
| New | +$1.56M |
|
|
HSNI
2272
DELISTED
HSN, Inc.
HSNI
| $1.74M | ﹤0.01% |
24,748
+10,828
| +78% | +$728K |
|
2273
CALL
Consolidated Edison
ED
$42B
| $1.74M | ﹤0.01% |
30,000
| – | – |
|
2274
CALL
Tenet Healthcare
THC
$21.9B
| $1.74M | ﹤0.01% |
30,000
| – | – |
|
|
SHOE
2275
Shoe Station Group
SHOE
$425M
| $1.73M | ﹤0.01% |
119,654
+37,324
| +45% | +$522K |
|
Similar funds
D.E. Shaw & Co's Q2 2015 Portfolio in Review
As of Q2 2015, D.E. Shaw & Co held 4,083 positions worth $67.1B, up 2.8% from $65.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co's Q2 2015 filing shows 504 new, 1,541 increased, 1,228 reduced and 364 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $479M.
By sector, the portfolio is most concentrated in Energy at 11% of assets, up from 9.7% a quarter earlier, followed by Technology and Healthcare.
- D.E. Shaw & Co's largest Q2 2015 buy was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M.
- D.E. Shaw & Co added most to Gilead Sciences in Q2 2015, an estimated $410M increase.
- D.E. Shaw & Co's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $479M.
- D.E. Shaw & Co fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q2 2015, selling an estimated $164M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $67.1B portfolio in Q2 2015.
- D.E. Shaw & Co opened 504 new positions and closed 364 in Q2 2015.
- D.E. Shaw & Co's portfolio value rose 2.8% quarter-over-quarter to $67.1B.
Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.